Pregnancy: There are no adequate data from the use of racecadotril in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, fertility, embryofoetal development, parturition or postnatal development. However, since no specific clinical studies are available, Hidrasec should not be administered to pregnant women.
Lactation: Due to the lack of information regarding racecadotril secretion in human milk, this product should not be administered to breastfeeding women.